Moreover, accumulating evidence indicates that MED23 (ranked 9th in patient TCGA-E2-A1LH) plays an oncogenic role in the development of NSCLC (a non-small cell lung cancer) and influences the invasiveness and development of tumors [59]. Here, MED23 is linked to non-small cell lung carcinoma.